愷英網絡(002517.SZ):部分董事、高管累計增持379.65萬股 增持計劃已完成
格隆匯 7 月 24日丨愷英網絡(002517.SZ)公佈,2020年7月1日,公司披露了董事長金鋒、副董事長兼副總經理沈軍、董事兼總經理陳永聰、董事兼代理總經理兼副總經理申亮、董事兼副總經理兼董事會祕書騫軍法、副總經理唐悦、副總經理趙凡、財務總監範波(“增持承諾人”)擬增持公司股份的計劃,增持承諾人擬自增持計劃披露之日起不超過6個月內增持公司股份不低於1650萬元。
自2020年7月13日至2020年7月23日,增持承諾人累計通過集中競價方式增持公司股份379.65萬股,佔公司總股本的0.18%,累計增持金額約1829.42萬元,此次增持計劃已完成。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.